Combining a sphingosine kinase inhibitor with temozolomide synergistically increases glioblastoma cell death: mechanism and clinical relevance

Ähnliche Einträge

• Comparative analysis of the effects of a sphingosine kinase inhibitor to temozolomide and radiation treatment on glioblastoma cell lines
  von: Cisneros Castillo, Liliana del Rocío, et al.
  Veröffentlicht: (2017)
• A novel HDAC inhibitor chidamide combined with imatinib synergistically targets tyrosine kinase inhibitor resistant chronic myeloid leukemia cells
  von: He, Bailin, et al.
  Veröffentlicht: (2020)
• The study of the mechanism of microglia-mediated glioma cytotoxicity reveals sphingosine kinase as a cancer-specific target for lysosomal cell death induction
  von: Mora Rodríguez, Rodrigo
  Veröffentlicht: (2009)
• Trimodal glioblastoma treatment consisting of concurrent radiotherapy, temozolomide, and the novel TGF-β receptor I kinase inhibitor LY2109761
  von: Zhang, Mengxian, et al.
  Veröffentlicht: (2011)
• Investigations on the combined effects of TGF beta receptor kinase inhibition, temozolomide and radiation therapy in the treatment of glioblastoma multiforme in vitro and in vivo
  von: Herion, Tobias W.
  Veröffentlicht: (2013)